ARK Investment Management LLC has recently launched two new exchange-traded funds (ETFs) in Europe focused on innovation and genomics. These ETFs are aimed at providing European investors with opportunities to invest in cutting-edge technology and advancements in the field of genomics.
The ARK Innovation ETF will focus on companies that are leading the way in disruptive innovation across various industries. This fund will provide exposure to companies that are at the forefront of technological advancements and are poised for future growth.
On the other hand, the ARK Genomic Revolution ETF will focus on companies that are driving advancements in genomics, including those involved in gene editing, genomic sequencing, and personalized medicine. This fund will give investors the opportunity to capitalize on the rapidly growing field of genomics and its potential to revolutionize healthcare and other industries.
Both of these ETFs are managed by ARK Investment Management, a well-known firm in the ETF space that is known for its focus on disruptive innovation and cutting-edge technologies. With the launch of these new ETFs in Europe, ARK is providing European investors with access to exciting opportunities in innovation and genomics.
Overall, these new ETFs from ARK offer European investors a chance to diversify their portfolios and potentially benefit from the growth and advancements in these exciting fields.